Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric Cancer × Irinotecan × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 364 Rectal Neoplasms 138 Colonic Neoplasms 137 Pancreatic Neoplasms 104 Stomach Neoplasms 102 Neoplasm Metastasis 63 Esophageal Neoplasms 56 Neoplasms 29 Esophageal Squamous Cell Carcinoma 29 Adenocarcinoma Of Esophagus 25 Gastrointestinal Neoplasms 15 Gallbladder Neoplasms 12 Biliary Tract Neoplasms 12 Cholangiocarcinoma 11 Breast Neoplasms 11 Adenocarcinoma 11 Liver Neoplasms 10 Digestive System Neoplasms 10 Colorectal Cancer Metastatic 10 Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Hepatocellular 10 Ovarian Neoplasms 9 Small Cell Lung Carcinoma 8 Bile Duct Neoplasms 8 Locally Advanced Rectal Cancer 7 Intestinal Neoplasms 7 Carcinoma 7 Digestive System Diseases 6 Appendiceal Neoplasms 6 Sarcoma 5

Interventions

Paclitaxel 9 apatinib 8 Capecitabine 7 Oxaliplatin 6 camrelizumab 5 Cisplatin 5 S 1 (combination) 4 Fluorouracil 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 Drug Therapy 2 vorolanib 1 trifluridine tipiracil drug combination 1 tipiracil 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 ezogabine 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01136031 2015-05-20

TI-2ndAGC

Seoul National University Hospital

Phase 1/2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡